Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · RAINBOW

RAINBOW

HealthcareHealthcare Services₹12773 cr market cap
₹1243.30 ▼ -1.17% today As of 19 Nov 2026
52-week low ₹1103.8052-week high ₹1598.60

-21.3% from the 52-week high · +14.0% above the low

Rainbow Children's Medicare Ltd. operates multi-specialty pediatric and obstetrics & gynecology hospitals. The company is headquartered in Hyderabad, Telangana and currently employs 3,581 full-time employees. The company went IPO on 2022-05-10. The firm is a multi-specialty pediatric, and obstetrics and gynecology hospital operating over 16 hospitals and three clinics in six cities, with a total bed capacity of approximately 1,655 beds. The company offers pediatric services under Rainbow Children’s Hospital, which include newborn and pediatric intensive care, pediatric multi-specialty services and pediatric quaternary care (including multi-organ transplants). Its women care services under Birthright by Rainbow that offers perinatal care services which includes normal and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility care along with gynecology services. The company also operates pediatric DNB training programs in private healthcare, offering post graduate residential DNB and fellowship programs. The company also provides a Rainbow Children’s Hospital mobile application.

The short version. RAINBOW reported revenue of ₹548 crore for Sep 2026, up 23.1% from a year earlier. Net profit was ₹82 crore (up 9.3% year on year). Return on equity was 16.9% in Mar 2026. Promoter holding was 49.83% in Sep 2026, down 0.02 points over 8 quarters.

1 · The price

How has the stock traded?

RAINBOW trades 21.3% below its 52-week high and 14.0% above its 52-week low.

Change over period: —

1M+1.8%
3M-13.9%
6M-6.3%
1Y-3.3%

2 · The business

Is it growing?

Sales, year on year+23.1%

Sep 2026 revenue of ₹548 cr.

Profit, year on year+9.3%

Sep 2026 net profit of ₹82 cr.

Net margin15.0%

1.9 pts lower than a year earlier.

3-year growth9.7% profit

Revenue compounded at 13.2% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue548470460445445353370398
Net profit8261777375535669
Net margin %15.012.916.816.316.915.215.217.3
EPS (₹)8.085.967.597.147.415.275.556.76

Annual

FY2026FY2025FY2024FY2023FY2022
Revenue1703151612971174974
Net profit278243217211138
Net margin %16.316.116.718.014.2
EPS (₹)27.4123.9721.3820.7713.62

3 · The quality

How well does it turn capital into profit?

Return on equity was 16.9% in Mar 2026; debt to equity is 0.00.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %16.916.617.219.9
Return on capital %16.818.117.520.6
EBITDA margin %33.634.534.935.5
Net margin %15.915.516.317.5

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR13.2%—
Profit CAGR9.7%—
Debt to equity0.00
Interest cover5.6x
Current ratio3.59
P/E ratio43.7

4 · The owners

Who holds it, and are they adding?

Promoter holding49.83%

Down 0.02 pts over 8 quarters.

Foreign institutions14.66%

Down 10.46 pts over 8 quarters.

Domestic institutions23.28%

Up 9.41 pts over 8 quarters.

Mutual fund schemes115

+21 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter49.8549.8549.8549.8549.8449.8449.8449.83-0.02
FII25.1223.6923.5921.8519.2317.2416.0314.66-10.46
DII13.8715.3115.4417.4619.4921.1322.5623.28+9.41
Public11.1611.1411.1110.8411.411.6711.3911.83+0.67

Mutual fund holdings · Oct 2026

115 schemes hold this stock

94 the month before.

  • TATA INDIA PHARMA & HEALTHCARE FUND4.02% of NAV
  • NJ ELSS Tax Saver Fund3.31% of NAV
  • Groww BSE Hospitals ETF2.85% of NAV
  • Bandhan Healthcare Fund2.81% of NAV
  • MOTILAL OSWAL SMALL CAP FUND2.35% of NAV
  • Shriram Multi Sector Rotation Fund2.33% of NAV
  • LIC MF HEALTHCARE FUND2.12% of NAV
  • Navi Flexi Cap Fund2.09% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for RAINBOW are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about RAINBOW

What is the RAINBOW share price?

RAINBOW (RAINBOW) last closed at ₹1,243.30, down 1.17% on the day. Its 52-week range is ₹1,103.80 to ₹1,598.60.

What is the market cap of RAINBOW?

RAINBOW has a market capitalisation of about ₹12,773 crore. Its price-to-earnings ratio is 43.7.

How are RAINBOW's latest results?

RAINBOW reported revenue of ₹548 crore for Sep 2026, up 23.1% from a year earlier. Net profit was ₹82 crore (up 9.3% year on year). Return on equity was 16.9% in Mar 2026. Promoter holding was 49.83% in Sep 2026, down 0.02 points over 8 quarters.

Who owns RAINBOW?

As of Sep 2026, shareholding was: Promoter 49.83%, FII 14.66%, DII 23.28%, Public 11.83%.

How many mutual funds hold RAINBOW?

115 mutual fund schemes held RAINBOW in October 2026. That compares with 94 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 27 Jun 2025 · Final Dividend - Rs. 3
  • 23 Jul 2024 · Final Dividend - Rs. 3
  • 22 Jun 2023 · Final Dividend - Rs. 3
  • 07 Sep 2022 · Final Dividend - Rs. 2

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.